Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial

Alan Winston*, Janaki Amin, Amanda Clarke, Laura Else, Alieu Amara, Andrew Owen, Tristan Barber, Heiko Jessen, Anchalee Avinghsanon, Ploenchan Chetchotisakd, Saye Khoo, David A. Cooper, Sean Emery, Rebekah Puls

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences